1. Anti-rheumatoid arthritis potential of different fractions derived from of Coluria longifolia
- Author
-
Yan-ping Gao, Qiuting Ma, Jian Liang, Qiang Wu, Yu-ye Zhu, Xi-de Ye, and Zhiyong Liu
- Subjects
Coluria longifolia ,Rheumatoid arthritis ,Anti-arthritic activity ,CIA rat model ,Mechanism ,Science (General) ,Q1-390 ,Social sciences (General) ,H1-99 - Abstract
Coluria longifolia Maxim (C. longifolia) is a Chinese folk medication commonly used to treat arthritis and joint pain. Literatures have reported that C. longifolia has significant anti-inflammatory, analgesic and antipyretic effects. The aim of this research was to assay the effective fractions of C. longifolia (EFCL) against rheumatoid arthritis (RA) and to elucidate its anti-RA mechanism on a preliminary basis. The rat model of collagen-induced arthritis (CIA) was established. The therapeutic effects of different fractions in vivo were evaluated by body weight changes, a foot swelling score, inflammatory factors and histopathological examination. The mechanism of EFCL was investigated by activity of oxidative stress related enzyme, qPCR and Western blotting tests. In vivo results showed that total extraction (TE) and n-butanol fraction (NF) could significantly alleviate the symptoms of RA, decrease the levels of IL-6 and TNF-α (P
- Published
- 2024
- Full Text
- View/download PDF